S. Ansorge, O. Henry, and A. Kamen, Recent progress in lentiviral vector mass production, Biochemical Engineering Journal, vol.48, issue.3, pp.362-77, 2010.
DOI : 10.1016/j.bej.2009.10.017

M. Carmo, A. Alves, and A. F. Rodrigues, Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer, The Journal of Gene Medicine, vol.73, issue.8, pp.670-678, 2009.
DOI : 10.1002/jgm.1353

R. I. Connor, Sensitivity of Non-Clade B Primary HIV-1 Isolates to Mildly Acidic pH, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.4, 2006.
DOI : 10.1097/01.qai.0000243048.50451.18

O. T. Fackler and B. M. Peterlin, Endocytic entry of HIV-1, Current Biology, vol.10, issue.16, pp.1005-1013, 2000.
DOI : 10.1016/S0960-9822(00)00654-0

D. Fenard, D. Ingrao, and A. Seye, Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells, Molecular Therapy - Nucleic Acids, vol.2, 2013.
DOI : 10.1038/mtna.2013.17

C. Frecha, J. Szecsi, and F. L. Cosset, Strategies for Targeting Lentiviral Vectors, Current Gene Therapy, vol.8, issue.6, 2008.
DOI : 10.2174/156652308786848003

F. Higashikawa and L. Chang, Kinetic Analyses of Stability of Simple and Complex Retroviral Vectors, Virology, vol.280, issue.1, pp.124-155, 2001.
DOI : 10.1006/viro.2000.0743

D. Ingrao, S. Majdoul, and A. K. Seye, Concurrent Measures of Fusion and Transduction Efficiency of Primary CD34+ Cells with Human Immunodeficiency Virus 1-Based Lentiviral Vectors Reveal Different Effects of Transduction Enhancers, Human Gene Therapy Methods, vol.25, issue.1, 2014.
DOI : 10.1089/hgtb.2013.090

URL : https://hal.archives-ouvertes.fr/inserm-00987203

A. Jacome, S. Navarro, and P. Rio, Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients, Molecular Therapy, vol.17, issue.6, 2009.
DOI : 10.1038/mt.2009.26

A. Leath and K. Cornetta, Developing Novel Lentiviral Vectors into Clinical Products, Methods Enzymol, vol.507, pp.89-108, 2012.
DOI : 10.1016/B978-0-12-386509-0.00005-3

T. Maurin, D. Fenard, and G. Lambeau, An Envelope-determined Endocytic Route of Viral Entry Allows HIV-1 to Escape from Secreted Phospholipase A2 Entry Blockade, Journal of Molecular Biology, vol.367, issue.3, pp.702-716, 2007.
DOI : 10.1016/j.jmb.2007.01.031

URL : https://hal.archives-ouvertes.fr/hal-00170737

O. W. Merten, State-of-the-art of the production of retroviral vectors, The Journal of Gene Medicine, vol.6, issue.S1, 2004.
DOI : 10.1002/jgm.499

O. W. Merten, S. Charrier, and N. Laroudie, Gene Therapy Application, Human Gene Therapy, vol.22, issue.3, pp.343-56, 2011.
DOI : 10.1089/hum.2010.060

V. Sandrin, B. Boson, and P. Salmon, Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates, Blood, vol.100, issue.3, pp.823-855, 2002.
DOI : 10.1182/blood-2001-11-0042

M. Schweizer and O. W. Merten, Large-Scale Production Means for the Manufacturing of Lentiviral Vectors, Current Gene Therapy, vol.10, issue.6, pp.474-86, 2010.
DOI : 10.2174/156652310793797748